Rani Therapeutics Holdings, Inc. (RANI)

$2.31 0.43% $0.01 Healthcare

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

$123.37M

Mr. Talat Imran

114.00

San Jose, CA

Mar 22, 2018

-1.96

$-1.18

1.32

13.32

0.00%

-1.00

2.12

0.00

13.01

-61.34%

-153.07%

Similar stocks (18)

Tyra Biosciences, Inc.

TYRA

$23.99 3.41%
Uptrend

EyePoint Pharmaceuticals, Inc.

EYPT

$9.18 3.03%
Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04%
Neutral

Corvus Pharmaceuticals, Inc.

CRVS

$5.61 2.37%
Uptrend

Biomea Fusion, Inc.

BMEA

$8.71 0.23%
Downtrend

Trevi Therapeutics, Inc.

TRVI

$3.50 2.64%
Uptrend

Cabaletta Bio, Inc.

CABA

$4.70 4.91%
Downtrend

Tenaya Therapeutics, Inc.

TNYA

$2.19 8.42%
Downtrend

ALX Oncology Holdings Inc.

ALXO

$2.17 1.40%
Downtrend

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66%
Downtrend

Protara Therapeutics, Inc.

TARA

$1.97 2.60%
Downtrend

Surrozen, Inc.

SRZN

$8.15 1.75%
Downtrend

Vincerx Pharma, Inc.

VINC

$0.70 1.67%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67%
Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21%
Neutral

Viracta Therapeutics, Inc.

VIRX

$0.22 2.23%
Downtrend

Vaccinex, Inc.

VCNX

$4.55 -11.99%
Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.16 10.00%
Downtrend

ETF Exposure (7)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend